Autologous bone marrow-derived cells for venous leg ulcers treatment: a pilot study.

  • publication
  • 01-02-2019

Otero G, Agorio C, Sujanov A, Echarte L, Tchekmedyian A, Montelongo M, Menyou A, Rodriguez A, Diaz L, Rodriguez I, Touriño C. Cytotherapy 2019 02;21(2):189-199. S1465-3249(19)30002-7. 10.1016/j.jcyt.2019.01.002.

Chronic venous leg ulcers (VLUs) are a common problem in clinical practice and available treatments are not satisfactory. The use of adjuvant therapies in combination with lower limb compression may lead to improved healing rates. Chronic wounds are candidates for new strategies in the emergent field of regenerative medicine. Bone marrow-derived cells (BMDCs) contain cells and secrete cytokines known to participate in wound healing. Thus, BMDC therapy seems a logical strategy for the treatment of chronic wounds. Our objective was to evaluate feasibility, safety and initial clinical outcome of autologous BMDC therapy associated with standard treatment in patients with VLUs.

see on Pubmed